174 related articles for article (PubMed ID: 22556374)
21. Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.
Márquez M; Fernández Gutiérrez del Álamo C; Girón-González JA
World J Gastroenterol; 2016 Jan; 22(4):1433-48. PubMed ID: 26819512
[TBL] [Abstract][Full Text] [Related]
22. HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.
Kearns A; Gordon J; Burdo TH; Qin X
J Am Coll Cardiol; 2017 Jun; 69(25):3084-3098. PubMed ID: 28641798
[TBL] [Abstract][Full Text] [Related]
23. Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection.
Hunt PW; Lee SA; Siedner MJ
J Infect Dis; 2016 Oct; 214 Suppl 2(Suppl 2):S44-50. PubMed ID: 27625430
[TBL] [Abstract][Full Text] [Related]
24. Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV Infection.
Hsu DC; Sereti I
Drugs; 2016 Apr; 76(5):533-49. PubMed ID: 26915027
[TBL] [Abstract][Full Text] [Related]
25. Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations.
Gresele P; Falcinelli E; Momi S; Francisci D; Baldelli F
Rev Cardiovasc Med; 2014; 15 Suppl 1():S9-20. PubMed ID: 24987863
[TBL] [Abstract][Full Text] [Related]
26. Inflammation, infection and atherosclerosis.
Shah PK
Trends Cardiovasc Med; 2019 Nov; 29(8):468-472. PubMed ID: 30733074
[TBL] [Abstract][Full Text] [Related]
27. Microbial translocation and microbiome dysbiosis in HIV-associated immune activation.
Zevin AS; McKinnon L; Burgener A; Klatt NR
Curr Opin HIV AIDS; 2016 Mar; 11(2):182-90. PubMed ID: 26679414
[TBL] [Abstract][Full Text] [Related]
28. Macrophages and Phospholipases at the Intersection between Inflammation and the Pathogenesis of HIV-1 Infection.
Spadaro F; Cecchetti S; Fantuzzi L
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28661459
[TBL] [Abstract][Full Text] [Related]
29. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
Hong S; Banks WA
Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
[TBL] [Abstract][Full Text] [Related]
30. [Association between inflammatory markers and microbial translocation in patients with human immunodeficiency virus infection taking antiretroviral treatment].
Reus Bañuls S; Portilla Sogorb J; Sanchez-Paya J; Boix Martínez V; Giner Oncina L; Frances R; Such J; Merino Lucas E; Gimeno Gascón A
Med Clin (Barc); 2014 Jan; 142(2):47-52. PubMed ID: 24120098
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology of coronary heart disease in patients with human immunodeficiency virus.
Triant VA
Rev Cardiovasc Med; 2014; 15 Suppl 1(0 1):S1-8. PubMed ID: 24987859
[TBL] [Abstract][Full Text] [Related]
32. HIV-specific immune dysregulation and atherosclerosis.
Zanni MV; Grinspoon SK
Curr HIV/AIDS Rep; 2012 Sep; 9(3):200-5. PubMed ID: 22638983
[TBL] [Abstract][Full Text] [Related]
33. B cells and atherosclerosis: A HIV perspective.
Obare LM; Bonami RH; Doran AC; Wanjalla CN
J Cell Physiol; 2024 Jun; 239(6):e31270. PubMed ID: 38651687
[TBL] [Abstract][Full Text] [Related]
34. Aging With Grace for People Living With HIV: Strategies to Overcome Leaky Gut and Cytomegalovirus Coinfection.
Routy JP; Royston L; Isnard S
J Acquir Immune Defic Syndr; 2022 Feb; 89(Suppl 1):S29-S33. PubMed ID: 35015743
[TBL] [Abstract][Full Text] [Related]
35. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
[TBL] [Abstract][Full Text] [Related]
36. Elevated Eosinophils as a Feature of Inflammation Associated With Hypertension in Virally Suppressed People Living With HIV.
Masenga SK; Elijovich F; Hamooya BM; Nzala S; Kwenda G; Heimburger DC; Mutale W; Munsaka SM; Zhao S; Koethe JR; Kirabo A
J Am Heart Assoc; 2020 Feb; 9(4):e011450. PubMed ID: 32064996
[TBL] [Abstract][Full Text] [Related]
37. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
[TBL] [Abstract][Full Text] [Related]
38. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
Gómez-Mora E; Massanella M; García E; Giles D; Bernadó M; Urrea V; Carrillo J; Ouchi D; Puig J; Negredo E; Clotet B; Blanco J; Cabrera C
PLoS One; 2017; 12(9):e0184433. PubMed ID: 28934217
[TBL] [Abstract][Full Text] [Related]
39. Microbial Translocation Does Not Drive Immune Activation in Ugandan Children Infected With HIV.
Fitzgerald FC; Lhomme E; Harris K; Kenny J; Doyle R; Kityo C; Shaw LP; Abongomera G; Musiime V; Cook A; Brown JR; Brooks A; Owen-Powell E; Gibb DM; Prendergast AJ; Sarah Walker A; Thiebaut R; Klein N;
J Infect Dis; 2019 Jan; 219(1):89-100. PubMed ID: 30107546
[TBL] [Abstract][Full Text] [Related]
40. Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction.
Maidji E; Somsouk M; Rivera JM; Hunt PW; Stoddart CA
PLoS Pathog; 2017 Feb; 13(2):e1006202. PubMed ID: 28241080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
